HDAX

HDAX Therapeutics is pioneering next-gen therapeutics for better patient outcomes. We are overcoming conventional challenges of HDAC6 targeting approaches with our novel dual binding mechanism to deliver a safe, effective, and long-lasting therapeutic solution for diseases driven by microtubule dysfunction, starting with peripheral neuropathies and cardiometabolic diseases.